SlideShare a Scribd company logo
1 of 16
Download to read offline
Phatophy
1, avenue Bourgelat
69280 Marcy l’Etoile, France
Tel. : + 33 4 78 87 17 37
www.phatophy.com
2
 Company
• Independent contract research organization (CRO) for
animal health and human pharmaceutical industries,
based in VetAgro Sup campus (F – Lyon area).
 Operates since 1981, acquisition of 100% of shares
by Phatobio SAS end of 2014
 Social Capital: 268 000 € (Phatobio SAS)
 Sales (TO): ~ 0,8 – 1 M€ / year
 Employees: 11 people (DVM, Study directors, QA
manager, Analysts) + trainees
 Member of LyonBiopole and AFSSI network
 Good Laboratory Practice accredited
 Partners
 IClB, PIGASE et BCL (experimental farms)
 HISTALIM, AVEPHARM, LABOVET, VOXCAN, BACTUP,
NEOBIOSYS, CHARLES RIVER…
 VetAgro Sup campus laboratories
 Services
 Advice & Expertise / Study Design
 Project Management in biological or pharmaceutical
product development
 Analysis of pharmaceutical and biological products
(R&D and Quality Control)
 Preclinical (In-vivo) and clinical veterinary studies
 Bioanalyses
 Regulatory affairs
 Quality Assurance
 Customers Customers
PHArmacology TOxicology PHYsiology
3
Sandrine COMBEAU
Part II Regulatory Affairs Manager
Céline SALVI
Biopharmaceutical Unit Manager
11 years of pro. exp.
Diploma: Master Analyses Physico-
chimiques et contrôle
Dr Jérôme THEVENON
Managing Director
Directeur d’Installation d’Essai
27 years of pro. exp. in AH industry
Docteur Veterinary Medicine, Microbiology &
Immunology Pasteur Inst., CESAM
Magalie CHAPEL
Preclinical & Clinical Unit
Manager
11 years of pro. exp.
Diploma: Master 2 Bio expérimentation
animale
Aud FROGER
Quality Assurance Manager
13 years of pro. exp.
Diploma: BTS Biological Analysis &
Biotechnology
A PROFESSIONAL AND EXPERIENCED TEAM
Sandrine COMBEAU
Bioanalysis/Pharma Study Director
16 years of pro. exp.
Diploma: DEA de Chimie Analytique
Jerome THEVENON
Regulatory Affairs Manager
Study Directors
Chemical engineers:
Emilie VENCK
Laetitial BESIN
Analysts:
Julien TRACOL
Melinda DOUCET
Julien TRACOL
Metrology
PC Study Director / Monitor
Emilie QUATRESOUS
Emilie VENCK
Archivist
Deputy Study Director
Trainees
Emilie QUATRESOUS
Part III & IV Reg. Affairs Manager
5 years of pro. exp.
Diploma: Master 2 Bio expérimentation
animale
Jerome THEVENON
Statistician
JEROME THEVENON EXPERIENCE
DVM, SPECIALIST R&D in Biopharmaceutical Industry
 Development of new drugs in Animal Health for 22 years
 CEVA SANTE ANIMALE (2004 - 2014) : Director of R&D Biological Projects (7
years) and Director of the Bacteriological and Immunological Development (3
years)
 MERIAL (1997 - 2004): Biological Project Leader – Veterinary Senior Clinician
(Bio and Pharma Projects)
 RHÔNE-MERIEUX (1992 - 1997): Research Associate and Head of Laboratory
 Diagnostic Laboratory and Veterinarians Analysis (1987 - 1992)
 Animal Health (autopsies, immunology, bacteriology, virology, epidemiological
investigations..., cattle, pigs, poultry, rabbits ...)
 Food safety (microbiological analyses)
 Veterinary practice – Production & Companion animals (1985-1987 and 1992)
Dr J Thevenon 4
Consulting / Expertise & Regulatory Affairs
 Consulting in biological and pharmaceutical
product development:
 Product specifications
 Development plan (roadmap)
 Regulatory strategy (gap analysis)
 Project management:
 Manufacturing process, active ingredient and
product control definition according to project
specifications
 Budget definition and monitoring
 Time schedule definition and monitoring
 Writing of variation / update dossier: Gap
analysis of existing product dossier versus
new regulatory guidelines or requirement.
 Writing of M. A. dossiers of party I (expertise), II
(Quality), III (Safety) and IV (efficacy) for National,
Decentralized or MR Procedures.
 Export dossier writing (outside EU).
 Meeting with Regulatory Agencies in EU for new
product development plan validation or existing
product renewal/variation strategy, Responses to
Questions of MA dossier submission.
5
Pharmaceutical Analyses
 Pharmaceutical Development
 Active ingredient and finished product dosage:
oral powders, drinking solutions, injectable solutions,
tablets, aerosols, feed…
 Setting and validation of analytical methods,
transfer
 Manufacturing in process control
 HPLC chemical analysis and physical-chemical
tests:
 pH, density, viscosity, melting point, Karl Fisher,
colorimetric tests...
 Dosages: HPLC, CPG, potentiometric titration
(active ingredients, preservatives, impurities)
 Pharmaceutical-technical tests: dissolution,
disaggregation, friability, rupture resistance,
compaction volume, density, viscosity, etc.
 Quality control:
Batch to batch quality control. Analytical support of in process
control validation and of cleaning validation.
 Microbiological Tests (with partners)
 Microbiological quality of pharmaceutical
preparations
 Antimicrobial preservative efficacy
 Microbiological antibiotic dosage
 Bacterial endotoxin quantification
 Sterility test
 Stability studies:
 Preliminary stability to select best formula
 Regulatory stability studies, in-use, on-going,
photostability in various climatic chambers
 Storage and management of samples in
ICH/VICH conditions with different temperature /
hygrometry levels: 6, 12, 24, 36, 48 and 60
months storage for all product and packaging
types (bags, jars, bottles, pipettes, boxes, vials,
aerosols, etc...).
6
Bioanalysis
A team of Study Directors with a solid background in
biological matrix analysis development and validation for
pharmacokinetic studies, residue depletion injection sites
and/or tissues (milk, eggs, blood, plasma, urine…)
analyses.
 Pharmacokinetics, bioequivalence
 KINETICA software, possible modeling with
Winonlin,
 ADME for all species, biodisponibility,
bioequivalence.
 Residue and metabolite studies
 Feasibility, development and remanence studies
7
Quality Assurance
 Independent Quality Assurance
Department:
 Review of all study plans, raw data
and final reports of GLP studies (Good
Laboratory Practices).
 Critical phase audits.
 Yearly quality assurance program
including SOP review.
 Equipment qualification and IT
validation.
 Study Director validates the study by
signing a Declaration of Conformity
attached to the study report.
 GLP accreditation by ANSES
 Independent Assurance Quality Department
 Internal metrology services
 Archiving System
8
9
Laboratory technical equipment
 Liquid Chromatography HPLC systems with different sensor modes: UV
(diode array), fluorescence, refractometer, electrochemistry,
 Acquisition software of liquid chromatography validated (Empower),
 Analytical balances and safety hood
 Dissolution device, tablet disintegration device, titrators (including Karl
Fisher), sifter, density meter, UV-visible spectrophotometer, viscosimeter
and many other laboratory equipment ...; appropriate equipment to
pharmacopoeia tests
10
Technical laboratory equipment
11
 Under the terms guidelines ICH / VICH: 7 climatic chambers from 1300
to 2000 liters, qualified and with GSM alarm 24 / 24h:
 25°C / 60% HR
 30°C / 65% HR
 40°C / 75% HR
 Other conditions on request
 Photostability (ex: 25°C / 60% HR, visible light 1.2 million
lux.hours)
Technical and storage equipment
Preclinical and clinical studies
A team of Study Directors / Monitors to organize, experiment and perform studies on all target species with the
most convenient partner site
 Pharmacokinetic studies after treatment by different routes for ADME, bioavailability, dose determination,
bio-equivalence, PK/PD analysis, etc.
 Systemic and local safety studies with clinical examination, blood-biochemistry, examination of injection
sites, gross examination, sampling for histo-pathology but also medical imaging by scan, IRM, echography.
 Residue depletion studies in foodstuffs of animal origin with validated analytical methods and in compliance
with MRLs and regulatory guidelines
 Palatability tests for any product (tablet, solution, mix the food), single administrations or long duration.
 Efficacy tests and challenge tests for antibiotics, vaccines, anti-parasitic, but also for additives or products
that do not need regulatory studies
 Pilot and proof of concept studies on target species
 Clinical trials field of Veterinary Medicinal Products compliant to GCP
12
13
Preclinical and clinical studies
 Efficacy and challenge tests:
 For antibiotics, vaccines, additives,…
 Various species : pig, poultry, ovine, bovine…
 Experimental infection or tested in naturally but
qualified infected animals
 Network of microbiological laboratories for
challenge suspension preparation and
quantification
 Clinical study – veterinary field trials
A team of Study Directors (monitor/investigators) entitled to experiment and perform
studies on all target species
14
Customer references
15
PHATOPHY Team
 Dr Jerome Thevenon
Managing Director
jerome.thevenon@phatophy.com
contact@phatophy.com
 +33 4 78 87 17 37
www.phatophy.com
16
Contact

More Related Content

What's hot

Changes to the regulation of autologous cells and tissues
Changes to the regulation of autologous cells and tissuesChanges to the regulation of autologous cells and tissues
Changes to the regulation of autologous cells and tissuesTGA Australia
 
Manuf sterility testing guidelines (tga) 2006
Manuf sterility testing guidelines (tga) 2006Manuf sterility testing guidelines (tga) 2006
Manuf sterility testing guidelines (tga) 2006Achmad Fauzi Al' Amrie
 
WHO Good Practices for Pharmaceutical Microbiology Laboratories
 WHO Good Practices for Pharmaceutical Microbiology Laboratories WHO Good Practices for Pharmaceutical Microbiology Laboratories
WHO Good Practices for Pharmaceutical Microbiology LaboratoriesPostgradoMLCC
 
LTD brochure_EN_20150104
LTD brochure_EN_20150104LTD brochure_EN_20150104
LTD brochure_EN_20150104Yan Zhi
 
Reserve sample maintenanace
Reserve sample maintenanaceReserve sample maintenanace
Reserve sample maintenanacedeepak mishra
 
Guideline on potency testing of cell based immunotherapy medicinal products f...
Guideline on potency testing of cell based immunotherapy medicinal products f...Guideline on potency testing of cell based immunotherapy medicinal products f...
Guideline on potency testing of cell based immunotherapy medicinal products f...National Institute of Biologics
 
Safety Monitoring of Natural Medicine
Safety Monitoring of Natural MedicineSafety Monitoring of Natural Medicine
Safety Monitoring of Natural MedicineLalit Singh
 
QC Method Validation for Biologicals vs Cell Therapy products (ATMP)
QC Method Validation for Biologicals vs Cell Therapy products (ATMP)QC Method Validation for Biologicals vs Cell Therapy products (ATMP)
QC Method Validation for Biologicals vs Cell Therapy products (ATMP)Ralph Jans
 
The regulation of biologicals in Australia
The regulation of biologicals in AustraliaThe regulation of biologicals in Australia
The regulation of biologicals in AustraliaTGA Australia
 
Immunological products quality control
Immunological products quality controlImmunological products quality control
Immunological products quality controlPh/Shaimaa Ahmadeen
 
Presentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissuesPresentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissuesTGA Australia
 
Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)TGA Australia
 
Panama rules
Panama rulesPanama rules
Panama rulesClapbio
 

What's hot (20)

Changes to the regulation of autologous cells and tissues
Changes to the regulation of autologous cells and tissuesChanges to the regulation of autologous cells and tissues
Changes to the regulation of autologous cells and tissues
 
Manuf sterility testing guidelines (tga) 2006
Manuf sterility testing guidelines (tga) 2006Manuf sterility testing guidelines (tga) 2006
Manuf sterility testing guidelines (tga) 2006
 
WHO Good Practices for Pharmaceutical Microbiology Laboratories
 WHO Good Practices for Pharmaceutical Microbiology Laboratories WHO Good Practices for Pharmaceutical Microbiology Laboratories
WHO Good Practices for Pharmaceutical Microbiology Laboratories
 
Q5 c step4
Q5 c step4Q5 c step4
Q5 c step4
 
basic tests for drugs
basic tests for drugsbasic tests for drugs
basic tests for drugs
 
LTD brochure_EN_20150104
LTD brochure_EN_20150104LTD brochure_EN_20150104
LTD brochure_EN_20150104
 
Reserve sample maintenanace
Reserve sample maintenanaceReserve sample maintenanace
Reserve sample maintenanace
 
Guideline on potency testing of cell based immunotherapy medicinal products f...
Guideline on potency testing of cell based immunotherapy medicinal products f...Guideline on potency testing of cell based immunotherapy medicinal products f...
Guideline on potency testing of cell based immunotherapy medicinal products f...
 
Paediatric committee
Paediatric committeePaediatric committee
Paediatric committee
 
Safety Monitoring of Natural Medicine
Safety Monitoring of Natural MedicineSafety Monitoring of Natural Medicine
Safety Monitoring of Natural Medicine
 
QC Method Validation for Biologicals vs Cell Therapy products (ATMP)
QC Method Validation for Biologicals vs Cell Therapy products (ATMP)QC Method Validation for Biologicals vs Cell Therapy products (ATMP)
QC Method Validation for Biologicals vs Cell Therapy products (ATMP)
 
Patient interaction with the EMA
Patient interaction with the EMAPatient interaction with the EMA
Patient interaction with the EMA
 
The regulation of biologicals in Australia
The regulation of biologicals in AustraliaThe regulation of biologicals in Australia
The regulation of biologicals in Australia
 
Immunological products quality control
Immunological products quality controlImmunological products quality control
Immunological products quality control
 
Presentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissuesPresentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissues
 
ICH [ Q ] Guidelines
ICH [ Q ] GuidelinesICH [ Q ] Guidelines
ICH [ Q ] Guidelines
 
Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)
 
pnl_05_en_006_web
pnl_05_en_006_webpnl_05_en_006_web
pnl_05_en_006_web
 
Panama rules
Panama rulesPanama rules
Panama rules
 
Evaluation of herbal drugs
Evaluation of herbal drugsEvaluation of herbal drugs
Evaluation of herbal drugs
 

Viewers also liked

evaluating MM waves
evaluating MM wavesevaluating MM waves
evaluating MM wavesSajid ali
 
Sistem komputer matkul Pengantar sistem komputer
Sistem komputer matkul Pengantar sistem komputerSistem komputer matkul Pengantar sistem komputer
Sistem komputer matkul Pengantar sistem komputerSelvhiee Rd
 
Biotechnology august2013-130926012214-phpapp02
Biotechnology august2013-130926012214-phpapp02Biotechnology august2013-130926012214-phpapp02
Biotechnology august2013-130926012214-phpapp02Supa Buoy
 
0601030 financial analysis
0601030 financial analysis0601030 financial analysis
0601030 financial analysisSupa Buoy
 
Designing & Managing Product
Designing & Managing ProductDesigning & Managing Product
Designing & Managing Productshilmihnisa Nisa
 
Visita al parque de tráfico 2014-15
Visita al parque de tráfico 2014-15Visita al parque de tráfico 2014-15
Visita al parque de tráfico 2014-151ciclo2013-14
 
Daily Ranger
Daily RangerDaily Ranger
Daily Rangerfluetlaw
 
Consumerdurable august2013-130926012304-phpapp02
Consumerdurable august2013-130926012304-phpapp02Consumerdurable august2013-130926012304-phpapp02
Consumerdurable august2013-130926012304-phpapp02Supa Buoy
 
Bar charts for questtionnaire
Bar charts for questtionnaireBar charts for questtionnaire
Bar charts for questtionnairedanielr97
 
SUSIE MATHEWS ABNEY and ASSOCIATES FOUNDATION
SUSIE MATHEWS ABNEY and ASSOCIATES FOUNDATIONSUSIE MATHEWS ABNEY and ASSOCIATES FOUNDATION
SUSIE MATHEWS ABNEY and ASSOCIATES FOUNDATIONkenradcliff19
 
Web sever tren vps
Web sever tren vpsWeb sever tren vps
Web sever tren vpsTuan Huy
 
Module youtobe
Module youtobeModule youtobe
Module youtobeTuan Huy
 
Module thong ke truy cap va footer
Module thong ke truy cap va footerModule thong ke truy cap va footer
Module thong ke truy cap va footerTuan Huy
 
Conceptos de proyecto
Conceptos de proyectoConceptos de proyecto
Conceptos de proyectomoisesmo19
 
Media presantation
Media presantationMedia presantation
Media presantationZaiddaman
 
南台經驗分享第二次會20140323
南台經驗分享第二次會20140323南台經驗分享第二次會20140323
南台經驗分享第二次會20140323Richard Lim
 

Viewers also liked (20)

BaiMau
BaiMauBaiMau
BaiMau
 
evaluating MM waves
evaluating MM wavesevaluating MM waves
evaluating MM waves
 
Sistem komputer matkul Pengantar sistem komputer
Sistem komputer matkul Pengantar sistem komputerSistem komputer matkul Pengantar sistem komputer
Sistem komputer matkul Pengantar sistem komputer
 
Biotechnology august2013-130926012214-phpapp02
Biotechnology august2013-130926012214-phpapp02Biotechnology august2013-130926012214-phpapp02
Biotechnology august2013-130926012214-phpapp02
 
0601030 financial analysis
0601030 financial analysis0601030 financial analysis
0601030 financial analysis
 
Designing & Managing Product
Designing & Managing ProductDesigning & Managing Product
Designing & Managing Product
 
Visita al parque de tráfico 2014-15
Visita al parque de tráfico 2014-15Visita al parque de tráfico 2014-15
Visita al parque de tráfico 2014-15
 
D isenoficuas
D isenoficuasD isenoficuas
D isenoficuas
 
Daily Ranger
Daily RangerDaily Ranger
Daily Ranger
 
Consumerdurable august2013-130926012304-phpapp02
Consumerdurable august2013-130926012304-phpapp02Consumerdurable august2013-130926012304-phpapp02
Consumerdurable august2013-130926012304-phpapp02
 
Bar charts for questtionnaire
Bar charts for questtionnaireBar charts for questtionnaire
Bar charts for questtionnaire
 
SUSIE MATHEWS ABNEY and ASSOCIATES FOUNDATION
SUSIE MATHEWS ABNEY and ASSOCIATES FOUNDATIONSUSIE MATHEWS ABNEY and ASSOCIATES FOUNDATION
SUSIE MATHEWS ABNEY and ASSOCIATES FOUNDATION
 
Web sever tren vps
Web sever tren vpsWeb sever tren vps
Web sever tren vps
 
El socialismo.
El socialismo.El socialismo.
El socialismo.
 
Readme
ReadmeReadme
Readme
 
Module youtobe
Module youtobeModule youtobe
Module youtobe
 
Module thong ke truy cap va footer
Module thong ke truy cap va footerModule thong ke truy cap va footer
Module thong ke truy cap va footer
 
Conceptos de proyecto
Conceptos de proyectoConceptos de proyecto
Conceptos de proyecto
 
Media presantation
Media presantationMedia presantation
Media presantation
 
南台經驗分享第二次會20140323
南台經驗分享第二次會20140323南台經驗分享第二次會20140323
南台經驗分享第二次會20140323
 

Similar to Phatophy presentation 2016 En

Sitec Presentation 140915
Sitec Presentation 140915Sitec Presentation 140915
Sitec Presentation 140915Sitec Labs
 
Resume Technical
Resume TechnicalResume Technical
Resume TechnicalBharat Naik
 
Antibiotic Residues In Milk, Risk For Consumers And Processors
Antibiotic Residues In Milk, Risk For Consumers And ProcessorsAntibiotic Residues In Milk, Risk For Consumers And Processors
Antibiotic Residues In Milk, Risk For Consumers And ProcessorsFrancois Stepman
 
Cell & Gene Therapy Preclinical Development Solutions
Cell & Gene Therapy Preclinical Development SolutionsCell & Gene Therapy Preclinical Development Solutions
Cell & Gene Therapy Preclinical Development SolutionsCovance
 
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, Mumbai
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, MumbaiLab Equipments By Thermo Fisher Scientific India Pvt. Ltd, Mumbai
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, MumbaiIndiaMART InterMESH Limited
 
Process development
Process developmentProcess development
Process development9160676107
 
LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016Yan Zhi
 
Scope, roles and responsibilities of microbiologist in
Scope, roles and responsibilities of microbiologist inScope, roles and responsibilities of microbiologist in
Scope, roles and responsibilities of microbiologist inAuricle Nissim
 
Good Laboratory Practices .pptx
Good Laboratory Practices .pptxGood Laboratory Practices .pptx
Good Laboratory Practices .pptxArchna53
 
Preclinical & clinical services in musculoskeletal field
Preclinical & clinical services in musculoskeletal fieldPreclinical & clinical services in musculoskeletal field
Preclinical & clinical services in musculoskeletal fieldArtialis SA
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Merck Life Sciences
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...MilliporeSigma
 
ICH GUIDELINES.pptx
ICH GUIDELINES.pptxICH GUIDELINES.pptx
ICH GUIDELINES.pptxAbdulNaim14
 
1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA
1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA
1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RAMichael Bonett
 
Master of pharmacy... Pharmaceutics ICH Giudelines
Master of pharmacy... Pharmaceutics ICH GiudelinesMaster of pharmacy... Pharmaceutics ICH Giudelines
Master of pharmacy... Pharmaceutics ICH Giudelinesomkarmandlik678
 
Company Profile Kalgen Innolab Innobiogram_2022.pptx
Company Profile Kalgen Innolab Innobiogram_2022.pptxCompany Profile Kalgen Innolab Innobiogram_2022.pptx
Company Profile Kalgen Innolab Innobiogram_2022.pptxasmadiarrum
 
ich guideline q,s,e,m
ich guideline q,s,e,mich guideline q,s,e,m
ich guideline q,s,e,mDsopMpharm
 

Similar to Phatophy presentation 2016 En (20)

Sitec Presentation 140915
Sitec Presentation 140915Sitec Presentation 140915
Sitec Presentation 140915
 
FCRL presentation
FCRL presentationFCRL presentation
FCRL presentation
 
Resume Technical
Resume TechnicalResume Technical
Resume Technical
 
Antibiotic Residues In Milk, Risk For Consumers And Processors
Antibiotic Residues In Milk, Risk For Consumers And ProcessorsAntibiotic Residues In Milk, Risk For Consumers And Processors
Antibiotic Residues In Milk, Risk For Consumers And Processors
 
Cell & Gene Therapy Preclinical Development Solutions
Cell & Gene Therapy Preclinical Development SolutionsCell & Gene Therapy Preclinical Development Solutions
Cell & Gene Therapy Preclinical Development Solutions
 
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, Mumbai
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, MumbaiLab Equipments By Thermo Fisher Scientific India Pvt. Ltd, Mumbai
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, Mumbai
 
Process development
Process developmentProcess development
Process development
 
LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016
 
2015-12-08_EnglishCV
2015-12-08_EnglishCV2015-12-08_EnglishCV
2015-12-08_EnglishCV
 
CV (Shikha)
CV (Shikha)CV (Shikha)
CV (Shikha)
 
Scope, roles and responsibilities of microbiologist in
Scope, roles and responsibilities of microbiologist inScope, roles and responsibilities of microbiologist in
Scope, roles and responsibilities of microbiologist in
 
Good Laboratory Practices .pptx
Good Laboratory Practices .pptxGood Laboratory Practices .pptx
Good Laboratory Practices .pptx
 
Preclinical & clinical services in musculoskeletal field
Preclinical & clinical services in musculoskeletal fieldPreclinical & clinical services in musculoskeletal field
Preclinical & clinical services in musculoskeletal field
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
ICH GUIDELINES.pptx
ICH GUIDELINES.pptxICH GUIDELINES.pptx
ICH GUIDELINES.pptx
 
1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA
1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA
1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA
 
Master of pharmacy... Pharmaceutics ICH Giudelines
Master of pharmacy... Pharmaceutics ICH GiudelinesMaster of pharmacy... Pharmaceutics ICH Giudelines
Master of pharmacy... Pharmaceutics ICH Giudelines
 
Company Profile Kalgen Innolab Innobiogram_2022.pptx
Company Profile Kalgen Innolab Innobiogram_2022.pptxCompany Profile Kalgen Innolab Innobiogram_2022.pptx
Company Profile Kalgen Innolab Innobiogram_2022.pptx
 
ich guideline q,s,e,m
ich guideline q,s,e,mich guideline q,s,e,m
ich guideline q,s,e,m
 

Phatophy presentation 2016 En

  • 1. Phatophy 1, avenue Bourgelat 69280 Marcy l’Etoile, France Tel. : + 33 4 78 87 17 37 www.phatophy.com
  • 2. 2  Company • Independent contract research organization (CRO) for animal health and human pharmaceutical industries, based in VetAgro Sup campus (F – Lyon area).  Operates since 1981, acquisition of 100% of shares by Phatobio SAS end of 2014  Social Capital: 268 000 € (Phatobio SAS)  Sales (TO): ~ 0,8 – 1 M€ / year  Employees: 11 people (DVM, Study directors, QA manager, Analysts) + trainees  Member of LyonBiopole and AFSSI network  Good Laboratory Practice accredited  Partners  IClB, PIGASE et BCL (experimental farms)  HISTALIM, AVEPHARM, LABOVET, VOXCAN, BACTUP, NEOBIOSYS, CHARLES RIVER…  VetAgro Sup campus laboratories  Services  Advice & Expertise / Study Design  Project Management in biological or pharmaceutical product development  Analysis of pharmaceutical and biological products (R&D and Quality Control)  Preclinical (In-vivo) and clinical veterinary studies  Bioanalyses  Regulatory affairs  Quality Assurance  Customers Customers PHArmacology TOxicology PHYsiology
  • 3. 3 Sandrine COMBEAU Part II Regulatory Affairs Manager Céline SALVI Biopharmaceutical Unit Manager 11 years of pro. exp. Diploma: Master Analyses Physico- chimiques et contrôle Dr Jérôme THEVENON Managing Director Directeur d’Installation d’Essai 27 years of pro. exp. in AH industry Docteur Veterinary Medicine, Microbiology & Immunology Pasteur Inst., CESAM Magalie CHAPEL Preclinical & Clinical Unit Manager 11 years of pro. exp. Diploma: Master 2 Bio expérimentation animale Aud FROGER Quality Assurance Manager 13 years of pro. exp. Diploma: BTS Biological Analysis & Biotechnology A PROFESSIONAL AND EXPERIENCED TEAM Sandrine COMBEAU Bioanalysis/Pharma Study Director 16 years of pro. exp. Diploma: DEA de Chimie Analytique Jerome THEVENON Regulatory Affairs Manager Study Directors Chemical engineers: Emilie VENCK Laetitial BESIN Analysts: Julien TRACOL Melinda DOUCET Julien TRACOL Metrology PC Study Director / Monitor Emilie QUATRESOUS Emilie VENCK Archivist Deputy Study Director Trainees Emilie QUATRESOUS Part III & IV Reg. Affairs Manager 5 years of pro. exp. Diploma: Master 2 Bio expérimentation animale Jerome THEVENON Statistician
  • 4. JEROME THEVENON EXPERIENCE DVM, SPECIALIST R&D in Biopharmaceutical Industry  Development of new drugs in Animal Health for 22 years  CEVA SANTE ANIMALE (2004 - 2014) : Director of R&D Biological Projects (7 years) and Director of the Bacteriological and Immunological Development (3 years)  MERIAL (1997 - 2004): Biological Project Leader – Veterinary Senior Clinician (Bio and Pharma Projects)  RHÔNE-MERIEUX (1992 - 1997): Research Associate and Head of Laboratory  Diagnostic Laboratory and Veterinarians Analysis (1987 - 1992)  Animal Health (autopsies, immunology, bacteriology, virology, epidemiological investigations..., cattle, pigs, poultry, rabbits ...)  Food safety (microbiological analyses)  Veterinary practice – Production & Companion animals (1985-1987 and 1992) Dr J Thevenon 4
  • 5. Consulting / Expertise & Regulatory Affairs  Consulting in biological and pharmaceutical product development:  Product specifications  Development plan (roadmap)  Regulatory strategy (gap analysis)  Project management:  Manufacturing process, active ingredient and product control definition according to project specifications  Budget definition and monitoring  Time schedule definition and monitoring  Writing of variation / update dossier: Gap analysis of existing product dossier versus new regulatory guidelines or requirement.  Writing of M. A. dossiers of party I (expertise), II (Quality), III (Safety) and IV (efficacy) for National, Decentralized or MR Procedures.  Export dossier writing (outside EU).  Meeting with Regulatory Agencies in EU for new product development plan validation or existing product renewal/variation strategy, Responses to Questions of MA dossier submission. 5
  • 6. Pharmaceutical Analyses  Pharmaceutical Development  Active ingredient and finished product dosage: oral powders, drinking solutions, injectable solutions, tablets, aerosols, feed…  Setting and validation of analytical methods, transfer  Manufacturing in process control  HPLC chemical analysis and physical-chemical tests:  pH, density, viscosity, melting point, Karl Fisher, colorimetric tests...  Dosages: HPLC, CPG, potentiometric titration (active ingredients, preservatives, impurities)  Pharmaceutical-technical tests: dissolution, disaggregation, friability, rupture resistance, compaction volume, density, viscosity, etc.  Quality control: Batch to batch quality control. Analytical support of in process control validation and of cleaning validation.  Microbiological Tests (with partners)  Microbiological quality of pharmaceutical preparations  Antimicrobial preservative efficacy  Microbiological antibiotic dosage  Bacterial endotoxin quantification  Sterility test  Stability studies:  Preliminary stability to select best formula  Regulatory stability studies, in-use, on-going, photostability in various climatic chambers  Storage and management of samples in ICH/VICH conditions with different temperature / hygrometry levels: 6, 12, 24, 36, 48 and 60 months storage for all product and packaging types (bags, jars, bottles, pipettes, boxes, vials, aerosols, etc...). 6
  • 7. Bioanalysis A team of Study Directors with a solid background in biological matrix analysis development and validation for pharmacokinetic studies, residue depletion injection sites and/or tissues (milk, eggs, blood, plasma, urine…) analyses.  Pharmacokinetics, bioequivalence  KINETICA software, possible modeling with Winonlin,  ADME for all species, biodisponibility, bioequivalence.  Residue and metabolite studies  Feasibility, development and remanence studies 7
  • 8. Quality Assurance  Independent Quality Assurance Department:  Review of all study plans, raw data and final reports of GLP studies (Good Laboratory Practices).  Critical phase audits.  Yearly quality assurance program including SOP review.  Equipment qualification and IT validation.  Study Director validates the study by signing a Declaration of Conformity attached to the study report.  GLP accreditation by ANSES  Independent Assurance Quality Department  Internal metrology services  Archiving System 8
  • 10.  Liquid Chromatography HPLC systems with different sensor modes: UV (diode array), fluorescence, refractometer, electrochemistry,  Acquisition software of liquid chromatography validated (Empower),  Analytical balances and safety hood  Dissolution device, tablet disintegration device, titrators (including Karl Fisher), sifter, density meter, UV-visible spectrophotometer, viscosimeter and many other laboratory equipment ...; appropriate equipment to pharmacopoeia tests 10 Technical laboratory equipment
  • 11. 11  Under the terms guidelines ICH / VICH: 7 climatic chambers from 1300 to 2000 liters, qualified and with GSM alarm 24 / 24h:  25°C / 60% HR  30°C / 65% HR  40°C / 75% HR  Other conditions on request  Photostability (ex: 25°C / 60% HR, visible light 1.2 million lux.hours) Technical and storage equipment
  • 12. Preclinical and clinical studies A team of Study Directors / Monitors to organize, experiment and perform studies on all target species with the most convenient partner site  Pharmacokinetic studies after treatment by different routes for ADME, bioavailability, dose determination, bio-equivalence, PK/PD analysis, etc.  Systemic and local safety studies with clinical examination, blood-biochemistry, examination of injection sites, gross examination, sampling for histo-pathology but also medical imaging by scan, IRM, echography.  Residue depletion studies in foodstuffs of animal origin with validated analytical methods and in compliance with MRLs and regulatory guidelines  Palatability tests for any product (tablet, solution, mix the food), single administrations or long duration.  Efficacy tests and challenge tests for antibiotics, vaccines, anti-parasitic, but also for additives or products that do not need regulatory studies  Pilot and proof of concept studies on target species  Clinical trials field of Veterinary Medicinal Products compliant to GCP 12
  • 13. 13 Preclinical and clinical studies  Efficacy and challenge tests:  For antibiotics, vaccines, additives,…  Various species : pig, poultry, ovine, bovine…  Experimental infection or tested in naturally but qualified infected animals  Network of microbiological laboratories for challenge suspension preparation and quantification  Clinical study – veterinary field trials A team of Study Directors (monitor/investigators) entitled to experiment and perform studies on all target species
  • 16.  Dr Jerome Thevenon Managing Director jerome.thevenon@phatophy.com contact@phatophy.com  +33 4 78 87 17 37 www.phatophy.com 16 Contact